focus -WSS

focus

author：comprehensive 2025-09-30 18:55:02 - browse：8929

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Millions may soon lose Medicaid when they don't have to

WSS

Four alarming medical procedures we’re glad history forgot

Inside the rise of 'mukbang' eating videos

Inside the rise of 'mukbang' eating videos

Four alarming medical procedures we’re glad history forgot

Bird flu in dairy cattle: New measures to control spread to humans

Researchers test human milk's ability to repair gut microbiome

knowledge

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

UnitedHealth, in a surprise, takes aim at Steward’s physician group

After affirmative action ruling, medical educators look to 'holistic review'

Insurer loopholes limit power of law against surprise medical bills

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A public health expert passes on football's full body collisions for youths

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The thinking behind the controversial eating disorder chatbot Tessa

Medical records are filled with copy

Republican states more likely to report Covid vaccine side effects

hotspot

Altering the blood type of lungs raises potential for universal organs for transplants

Senate panel passes drug pricing bills, but drops one PBM reform

Hundreds died while taking an arthritis drug, but nobody alerted patients

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Medicare Advantage 2025 payments will dip, Biden administration says

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Wikipedia

explore

entertainment

leisure time